Millrace Asset Group, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Millrace Asset Group, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,726
-2.1%
19,264
-7.0%
2.13%
+15.4%
Q2 2023$1,763
-99.8%
20,706
+109.7%
1.85%
+24.3%
Q1 2020$984,000
-41.6%
9,872
-32.7%
1.49%
-18.9%
Q4 2019$1,685,000
+17.2%
14,665
+28.6%
1.83%
+8.7%
Q3 2019$1,438,000
+32.8%
11,400
+26.7%
1.69%
+50.5%
Q2 2019$1,083,0009,0001.12%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders